IL197396A - Pharmaceutical combination of ethinylestradiol and drospirenone for use as a contraceptive - Google Patents

Pharmaceutical combination of ethinylestradiol and drospirenone for use as a contraceptive

Info

Publication number
IL197396A
IL197396A IL197396A IL19739609A IL197396A IL 197396 A IL197396 A IL 197396A IL 197396 A IL197396 A IL 197396A IL 19739609 A IL19739609 A IL 19739609A IL 197396 A IL197396 A IL 197396A
Authority
IL
Israel
Prior art keywords
drospirenone
daily dosage
ethinylestradiol
dosage units
composition
Prior art date
Application number
IL197396A
Other languages
English (en)
Original Assignee
Bayer Schering Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26153358&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL197396(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from PCT/IB2000/001213 external-priority patent/WO2001015701A1/en
Application filed by Bayer Schering Pharma Ag filed Critical Bayer Schering Pharma Ag
Publication of IL197396A publication Critical patent/IL197396A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A61K31/585—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin containing lactone rings, e.g. oxandrolone, bufalin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
IL197396A 1999-08-31 2009-03-04 Pharmaceutical combination of ethinylestradiol and drospirenone for use as a contraceptive IL197396A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US24095399P 1999-08-31 1999-08-31
EP99202826 1999-08-31
PCT/IB2000/001213 WO2001015701A1 (en) 1999-08-31 2000-08-31 Pharmaceutical combination of ethinylestradiol and drospirenone for use as a contraceptive

Publications (1)

Publication Number Publication Date
IL197396A true IL197396A (en) 2010-04-29

Family

ID=26153358

Family Applications (2)

Application Number Title Priority Date Filing Date
IL197396A IL197396A (en) 1999-08-31 2009-03-04 Pharmaceutical combination of ethinylestradiol and drospirenone for use as a contraceptive
IL200482A IL200482A0 (en) 1999-08-31 2009-08-19 Pharmaceutical combination of ethinylestradiol and drospirenone for use as a contraceptive

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL200482A IL200482A0 (en) 1999-08-31 2009-08-19 Pharmaceutical combination of ethinylestradiol and drospirenone for use as a contraceptive

Country Status (11)

Country Link
CN (1) CN1223350C (ru)
BG (2) BG65204B1 (ru)
CA (1) CA2382426C (ru)
EE (1) EE05317B1 (ru)
HR (1) HRP20020258B1 (ru)
IL (2) IL197396A (ru)
MX (1) MXPA02002043A (ru)
NO (3) NO327588B3 (ru)
RU (4) RU2269342C2 (ru)
SK (1) SK287634B6 (ru)
UA (1) UA81387C2 (ru)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1625849A1 (en) * 2004-08-09 2006-02-15 Liconsa, Liberacion Controlada de Sustancias Activas, S.A. Pharmaceutical composition comprising drospirenone and ethynylestradiol
CN101489563A (zh) * 2006-07-06 2009-07-22 拜耳先灵医药股份有限公司 用于避孕和预防先天性畸形风险的药物制剂
US9301920B2 (en) 2012-06-18 2016-04-05 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
BR112014012444B1 (pt) 2011-11-23 2021-12-14 Therapeuticsmd, Inc Composição farmacêutica compreendendo estradiol solubilizado, progesterona e um agente de solubilização, bem como usos desta para tratar um sintoma relacionado à menopausa em uma mulher
RU2618471C2 (ru) * 2012-12-03 2017-05-03 Закрытое Акционерное Общество "Вертекс" Пероральная фармацевтическая композиция диуретика и ингибитора АПФ в микронизированной форме, лекарственное средство и его применение
US11266661B2 (en) 2012-12-21 2022-03-08 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
JP2017516768A (ja) 2014-05-22 2017-06-22 セラピューティックスエムディー インコーポレーテッドＴｈｅｒａｐｅｕｔｉｃｓｍｄ， Ｉｎｃ． 天然の併用ホルモン補充療法剤及び療法
CN108606963B (zh) * 2017-12-27 2021-05-18 上海长海医院 含有屈螺酮和雌激素的复方避孕贴、制备方法及应用
CN111529482A (zh) * 2020-05-20 2020-08-14 祝培 十一酸睾酮缓释植入剂及其应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2652761C2 (de) * 1976-11-16 1985-11-21 Schering AG, 1000 Berlin und 4709 Bergkamen 15,16-Methylen-Spirolactone, Verfahren zu deren Herstellung und diese enthaltende Arzneimittel
DE4344462C2 (de) * 1993-12-22 1996-02-01 Schering Ag Zusammensetzung für die Empfängnisverhütung
DE4411585A1 (de) * 1994-03-30 1995-10-05 Schering Ag Pharmazeutisches Kombinationspräparat zur hormonalen Kontrazeption
ES2223081T3 (es) * 1996-07-26 2005-02-16 Wyeth Metodo anticonceptivo oral monofasico y kit que comprende una combinacion de progestina y estrogeno.

Also Published As

Publication number Publication date
RU2010114825A (ru) 2011-10-20
HRP20020258B1 (en) 2007-05-31
RU2449796C2 (ru) 2006-02-10
BG65204B1 (bg) 2007-07-31
MXPA02002043A (es) 2003-08-20
IL200482A0 (en) 2011-07-31
CN1223350C (zh) 2005-10-19
SK287634B6 (sk) 2011-04-05
UA81387C2 (en) 2008-01-10
EE200900049A (et) 2009-10-15
CN1407895A (zh) 2003-04-02
RU2396082C2 (ru) 2010-08-10
RU2449796C9 (ru) 2007-10-27
NO2010004I1 (no) 2010-03-22
RU2005131868A (ru) 2007-04-20
NO327588B3 (no) 2011-05-16
RU2269342C9 (ru) 2007-10-27
NO327588B1 (no) 2009-08-31
EE05317B1 (et) 2010-08-16
RU2269342C2 (ru) 2006-02-10
BG109749A (bg) 2008-06-30
CA2382426C (en) 2006-02-28
BG106533A (bg) 2002-10-31
HRP20020258A2 (en) 2005-02-28
NO20083854L (no) 2002-04-26
RU2482853C2 (ru) 2013-05-27
SK2572002A3 (en) 2002-11-06
CA2382426A1 (en) 2001-03-08
NO20091809L (no) 2002-04-26

Similar Documents

Publication Publication Date Title
AU2009200247B2 (en) Pharmaceutical combination of ethinylestradiol and drospirenone for use as a contraceptive
US6787531B1 (en) Pharmaceutical composition for use as a contraceptive
IL197396A (en) Pharmaceutical combination of ethinylestradiol and drospirenone for use as a contraceptive
EP2305267A2 (en) Pharmaceutical combination of ethinylestradiol and drospirenone for use as a contraceptive
AU2014227490A1 (en) Pharmaceutical combination of ethinylestradiol and drospirenone for use as a contraceptive
ZA200404083B (en) Pharmaceutical combination of ethinylestradiol anddrospirenone for use as a contraceptive.

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
KB Patent renewed